Article
Stage-dependent transcriptional regulation of ICOS across metabolic liver disease progression and hepatocellular carcinoma
2026-02-11
Abstract excerpt
<title>Abstract</title> <p>Background and Aim Metabolic dysfunction–associated steatotic liver disease (MASLD) can progress to metabolic dysfunction–associated steatohepatitis (MASH), cirrhosis, and eventually hepatocellular carcinoma (HCC). About 30% of HCC patients die within five years, highlighting an urgent need for early intervention and understanding of disease mechanisms. Immune dysregulation is a key fa...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e1b49c4e-51c5-5ae3-880e-544c2c478ed5
- DOI
- 10.21203/rs.3.rs-8834306/v1
